We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
26
Agilent Technologies
A
$39.1B
$3.82M 0.65%
25,541
+14,663
+135% +$2.09M
PCAR icon
27
PACCAR
PCAR
$69.8B
$3.81M 0.65%
57,809
+9,248
+19% +$604K
AAPL icon
28
Apple
AAPL
$4.54T
$3.77M 0.64%
+29,023
New +$4.15M
CNC icon
29
Centene
CNC
$30.7B
$3.66M 0.62%
44,684
-23,522
-34% -$1.92M
ISRG icon
30
Intuitive Surgical
ISRG
$127B
$3.64M 0.62%
13,717
+1,256
+10% +$306K
CTSH icon
31
Cognizant
CTSH
$24.9B
$3.49M 0.59%
61,037
+6,272
+11% +$368K
LRCX icon
32
Lam Research
LRCX
$367B
$3.42M 0.58%
81,280
+55,830
+219% +$2.34M
PANW icon
33
Palo Alto Networks
PANW
$270B
$3.41M 0.58%
48,842
+9,960
+26% +$800K
ROST icon
34
Ross Stores
ROST
$80.5B
$3.31M 0.56%
+28,524
New +$2.91M
STLD icon
35
Steel Dynamics
STLD
$36B
$3.27M 0.55%
33,444
-4,678
-12% -$450K
NEE icon
36
NextEra Energy
NEE
$181B
$3.26M 0.55%
39,003
-4,910
-11% -$397K
RCL icon
37
Royal Caribbean
RCL
$85.1B
$3.14M 0.53%
63,473
+54,371
+597% +$2.85M
BAX icon
38
Baxter International
BAX
$13.5B
$3.13M 0.53%
+61,334
New +$3.29M
CARR icon
39
Carrier Global
CARR
$51B
$3.09M 0.52%
74,868
+13,398
+22% +$544K
FAST icon
40
Fastenal
FAST
$54.7B
$3.04M 0.52%
128,578
+118,376
+1,160% +$2.89M
NUE icon
41
Nucor
NUE
$58.6B
$3.01M 0.51%
22,854
+15,765
+222% +$2.14M
BIIB icon
42
Biogen
BIIB
$30B
$2.92M 0.5%
10,554
+1,512
+17% +$427K
JNJ icon
43
Johnson & Johnson
JNJ
$618B
$2.89M 0.49%
+16,379
New +$2.83M
ITW icon
44
Illinois Tool Works
ITW
$82.6B
$2.89M 0.49%
13,121
+6,088
+87% +$1.3M
GM icon
45
General Motors
GM
$80.4B
$2.86M 0.49%
85,140
+73,685
+643% +$2.72M
HD icon
46
Home Depot
HD
$331B
$2.86M 0.49%
9,053
-7,140
-44% -$2.18M
ABT icon
47
Abbott
ABT
$183B
$2.84M 0.48%
25,835
+8,051
+45% +$834K
PEP icon
48
PepsiCo
PEP
$190B
$2.8M 0.48%
+15,513
New +$2.77M
AMAT icon
49
Applied Materials
AMAT
$403B
$2.79M 0.47%
28,614
+878
+3% +$84.2K
HCA icon
50
HCA Healthcare
HCA
$87.2B
$2.77M 0.47%
11,540
+5,055
+78% +$1.13M
1
2
3 4 5

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.